Cargando…

Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes

Bitter Melon (Momordica charantia) is a widely used traditional remedy for hyperglycemia. While the medicinal properties of this plant have been studied extensively using in vitro and animal models, the clinical efficacy and safety in humans is largely unknown. This review discusses the benefits and...

Descripción completa

Detalles Bibliográficos
Autores principales: Efird, Jimmy T., Choi, Yuk Ming, Davies, Stephen W., Mehra, Sanjay, Anderson, Ethan J., Katunga, Lalage A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945602/
https://www.ncbi.nlm.nih.gov/pubmed/24566057
http://dx.doi.org/10.3390/ijerph110202328
_version_ 1782306550310764544
author Efird, Jimmy T.
Choi, Yuk Ming
Davies, Stephen W.
Mehra, Sanjay
Anderson, Ethan J.
Katunga, Lalage A.
author_facet Efird, Jimmy T.
Choi, Yuk Ming
Davies, Stephen W.
Mehra, Sanjay
Anderson, Ethan J.
Katunga, Lalage A.
author_sort Efird, Jimmy T.
collection PubMed
description Bitter Melon (Momordica charantia) is a widely used traditional remedy for hyperglycemia. While the medicinal properties of this plant have been studied extensively using in vitro and animal models, the clinical efficacy and safety in humans is largely unknown. This review discusses the benefits and limitations of bitter melon supplementation in the context of epidemic levels of insulin resistance and pre-diabetes throughout the world.
format Online
Article
Text
id pubmed-3945602
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-39456022014-03-10 Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes Efird, Jimmy T. Choi, Yuk Ming Davies, Stephen W. Mehra, Sanjay Anderson, Ethan J. Katunga, Lalage A. Int J Environ Res Public Health Bitter Melon (Momordica charantia) is a widely used traditional remedy for hyperglycemia. While the medicinal properties of this plant have been studied extensively using in vitro and animal models, the clinical efficacy and safety in humans is largely unknown. This review discusses the benefits and limitations of bitter melon supplementation in the context of epidemic levels of insulin resistance and pre-diabetes throughout the world. MDPI 2014-02-21 2014-02 /pmc/articles/PMC3945602/ /pubmed/24566057 http://dx.doi.org/10.3390/ijerph110202328 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Efird, Jimmy T.
Choi, Yuk Ming
Davies, Stephen W.
Mehra, Sanjay
Anderson, Ethan J.
Katunga, Lalage A.
Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes
title Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes
title_full Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes
title_fullStr Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes
title_full_unstemmed Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes
title_short Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes
title_sort potential for improved glycemic control with dietary momordica charantia in patients with insulin resistance and pre-diabetes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945602/
https://www.ncbi.nlm.nih.gov/pubmed/24566057
http://dx.doi.org/10.3390/ijerph110202328
work_keys_str_mv AT efirdjimmyt potentialforimprovedglycemiccontrolwithdietarymomordicacharantiainpatientswithinsulinresistanceandprediabetes
AT choiyukming potentialforimprovedglycemiccontrolwithdietarymomordicacharantiainpatientswithinsulinresistanceandprediabetes
AT daviesstephenw potentialforimprovedglycemiccontrolwithdietarymomordicacharantiainpatientswithinsulinresistanceandprediabetes
AT mehrasanjay potentialforimprovedglycemiccontrolwithdietarymomordicacharantiainpatientswithinsulinresistanceandprediabetes
AT andersonethanj potentialforimprovedglycemiccontrolwithdietarymomordicacharantiainpatientswithinsulinresistanceandprediabetes
AT katungalalagea potentialforimprovedglycemiccontrolwithdietarymomordicacharantiainpatientswithinsulinresistanceandprediabetes